|
Roldan V, Lecumberri R, Muñoz-Torrero JF, Vicente V, Rocha E, Brenner B, Monreal M; RIETE Investigators. Thrombophilia testing in patients with venous thromboembolism. Findings from the RIETE registry. Thromb Res. 2009 Jun;124(2):174-7. doi: 10.1016/j.thromres.2008.11.003. Epub 2008 Dec 20. PubMed PMID: 19101711.
AÑO: 2009; IF: 2.406
|
19101711
|
Navarro-Núñez L, Roldán V, Lozano ML, Rivera J, Marin F, Vicente V, Martínez C. TUBB1 Q43P polymorphism does not protect against acute coronary syndrome and premature myocardial infarction. Thromb Haemost. 2008 Dec;100(6):1211-3. PubMed PMID: 19132255.
AÑO: 2008; IF: 3.803
|
|
Cambronero F, Marín F, Roldán V, Hernández-Romero D, Valdés M, Lip GY. Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis. Eur Heart J. 2009 Jan;30(2):139-51. doi: 10.1093/eurheartj/ehn538. Epub 2009 Jan 9. Review. PubMed PMID: 19136482.
AÑO: 2009; IF: 9.8
|
|
Ruiz-Nodar JM, Marín F, Sánchez-Payá J, Hurtado JA, Valencia-Martín J, Manzano-Fernández S, Roldán V, Pérez-Andreu V, Sogorb F, Valdés M, Lip GY. Efficacy and safety of drug-eluting stent use in patients with atrial fibrillation. Eur Heart J. 2009 Apr;30(8):932-9. doi: 10.1093/eurheartj/ehp045. Epub 2009 Feb 26. PubMed PMID: 19246502.
AÑO: 2009; IF: 9.8
|
|
Pérez-Andreu V, Roldán V, Antón AI, García-Barberá N, Corral J, Vicente V, González-Conejero R. Pharmacogenetic relevance of CYP4F2 V433M polymorphism on acenocoumarol therapy. Blood. 2009 May 14;113(20):4977-9. doi: 10.1182/blood-2008-09-176222. Epub 2009 Mar 6. PubMed PMID: 19270263.
AÑO: 2009; IF: 10.555
|